- Home
- VERO vs SHPH Comparison
VERO vs SHPH Comparison
Compare VERO & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- SHPH
- Stock Information
- Founded
- VERO N/A
- SHPH 2012
- Country
- VERO Canada
- SHPH United States
- Employees
- VERO N/A
- SHPH N/A
- Industry
- VERO Medical/Dental Instruments
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- SHPH Health Care
- Exchange
- VERO Nasdaq
- SHPH Nasdaq
- Market Cap
- VERO 2.4M
- SHPH 2.2M
- IPO Year
- VERO N/A
- SHPH 2022
- Fundamental
- Price
- VERO $2.26
- SHPH $0.42
- Analyst Decision
- VERO
- SHPH
- Analyst Count
- VERO 0
- SHPH 0
- Target Price
- VERO N/A
- SHPH N/A
- AVG Volume (30 Days)
- VERO 68.1K
- SHPH 262.2K
- Earning Date
- VERO 03-31-2025
- SHPH 05-12-2025
- Dividend Yield
- VERO N/A
- SHPH N/A
- EPS Growth
- VERO N/A
- SHPH N/A
- EPS
- VERO N/A
- SHPH N/A
- Revenue
- VERO $64,833,000.00
- SHPH N/A
- Revenue This Year
- VERO N/A
- SHPH N/A
- Revenue Next Year
- VERO $4.95
- SHPH N/A
- P/E Ratio
- VERO N/A
- SHPH N/A
- Revenue Growth
- VERO N/A
- SHPH N/A
- 52 Week Low
- VERO $2.20
- SHPH $0.33
- 52 Week High
- VERO $17.49
- SHPH $4.71
- Technical
- Relative Strength Index (RSI)
- VERO 38.89
- SHPH 40.73
- Support Level
- VERO $2.46
- SHPH $0.35
- Resistance Level
- VERO $4.03
- SHPH $0.44
- Average True Range (ATR)
- VERO 0.46
- SHPH 0.05
- MACD
- VERO -0.03
- SHPH 0.01
- Stochastic Oscillator
- VERO 3.28
- SHPH 55.35
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.